$Recursion Pharmaceuticals(RXRX.US) fell more than 7%; AI drug discovery small caps couldn't withstand rate hike expecta…
$Recursion Pharmaceuticals(RXRX.US) fell more than 7%; AI drug discovery small caps couldn't withstand rate hike expectations, and cash-burning biotechs are too sensitive to interest rates. 😔
$SPDR S&P Biotech(XBI.US), $Intuitive Surgical(ISRG.US) also saw slight declines. The healthcare sector overall is weak, though large caps fell more gently. Those holding $Recursion Pharmaceuticals(RXRX.US) can only wait for clinical data to speak.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
